Hofheinz, R., Bruix, J., Demetri, G. D., Grothey, A., Marian, M., Bartsch, J., & Odom, D. (2021). Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types. Cancer management and research, 13, . https://doi.org/10.2147/CMAR.S305939
Chicago-Zitierstil (17. Ausg.)Hofheinz, Ralf-Dieter, Jordi Bruix, George D. Demetri, Axel Grothey, Marisca Marian, Jennifer Bartsch, und Dawn Odom. "Effect of Regorafenib in Delaying Definitive Deterioration in Health-related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types." Cancer Management and Research 13 (2021). https://doi.org/10.2147/CMAR.S305939.
MLA-Zitierstil (9. Ausg.)Hofheinz, Ralf-Dieter, et al. "Effect of Regorafenib in Delaying Definitive Deterioration in Health-related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types." Cancer Management and Research, vol. 13, 2021, https://doi.org/10.2147/CMAR.S305939.